Ergocalciferol

Generic Name
Ergocalciferol
Brand Names
Drisdol, Mvi Pediatric
Drug Type
Small Molecule
Chemical Formula
C28H44O
CAS Number
50-14-6
Unique Ingredient Identifier
VS041H42XC
Background

Ergocalciferol is an inactivated vitamin D analog. It is synthesized by some plants in the presence of UVB light. The production of ergocalciferol was prompted by the identification of dietary deficiency, more specifically vitamin D, as the main causative factor for the development of rickets. Ergocalciferol was isolated for the first time from yeast in 1931...

Indication

Ergocalciferol is indicated for the treatment of hypoparathyroidism, refractory rickets, and familial hypophosphatemia.

Hypoparathyroidism is the result of inadequate parathyroid hormone production that occurs due to the presence of damage or removal of the parathyroid glands. This condition produces decreased calcium and increased phosphorus levels.
...

Associated Conditions
Deficiency, Vitamin A, Deficiency, Vitamin D, Hypoparathyroidism, Hypophosphatemia, Familial, Vitamin D Resistant Rickets
Associated Therapies
Dietary supplementation

Treatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis

First Posted Date
2011-08-31
Last Posted Date
2017-03-20
Lead Sponsor
Johns Hopkins University
Target Recruit Count
139
Registration Number
NCT01426347
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

Sustainability of Vitamin D Levels After Repletion With Ergocalciferol In Chronic Kidney Disease Stage 5D

First Posted Date
2011-03-10
Last Posted Date
2016-01-14
Lead Sponsor
Albany College of Pharmacy and Health Sciences
Target Recruit Count
20
Registration Number
NCT01312441
Locations
🇺🇸

Stratton VA Medical Center, Albany, New York, United States

🇺🇸

Hortense and Louis Rubin Dialysis Center, Troy, New York, United States

Vitamin D Repletion in Stone Formers With Hypercalciuria

First Posted Date
2011-02-15
Last Posted Date
2012-10-23
Lead Sponsor
New York Presbyterian Hospital
Target Recruit Count
30
Registration Number
NCT01295879
Locations
🇺🇸

New York Presbyterian Hospital, New York, New York, United States

Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients

First Posted Date
2010-08-02
Last Posted Date
2017-04-04
Lead Sponsor
The Cleveland Clinic
Target Recruit Count
19
Registration Number
NCT01173848
Locations
🇺🇸

Cleveland Clinic, Cleveland, Ohio, United States

Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes

First Posted Date
2010-06-30
Last Posted Date
2011-04-07
Lead Sponsor
Cook County Health
Target Recruit Count
117
Registration Number
NCT01153243

hCAP18 Levels and Vitamin D Deficiency in Chronic Kidney Disease

First Posted Date
2009-12-04
Last Posted Date
2015-09-23
Lead Sponsor
Massachusetts General Hospital
Registration Number
NCT01026363
Locations
🇺🇸

Massachusetts Institute of Technology, Cambridge, Massachusetts, United States

Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients

First Posted Date
2009-08-13
Last Posted Date
2011-03-24
Lead Sponsor
Salem Veterans Affairs Medical Center
Target Recruit Count
80
Registration Number
NCT00958451
Locations
🇺🇸

VA Medical Center, Salem, Virginia, United States

DIVINE: Dialysis Infection and Vitamin D In New England

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2009-05-04
Last Posted Date
2018-04-20
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
105
Registration Number
NCT00892099
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Brigham and Women's Hospital, Boston, Massachusetts, United States

hCAP18 Levels and Vitamin D Deficiency in Healthy Subjects

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2008-08-27
Last Posted Date
2016-04-14
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
99
Registration Number
NCT00742235
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

A Randomised, Controlled Comparison of Vitamin D Strategies is Acute Hip Fracture Patients

Phase 4
Completed
Conditions
Interventions
First Posted Date
2007-01-19
Last Posted Date
2012-06-14
Lead Sponsor
Hamilton Health Sciences Corporation
Target Recruit Count
64
Registration Number
NCT00424619
© Copyright 2024. All Rights Reserved by MedPath